International Collaborations

• Department of Radiation Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, USA. Prof Chowdhury Dipanjan
• MD Anderson Cancer Center, University of Texas, Texas, USA. Prof Christopher J Logothetis
• Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. Prof Jiri Lukas
• Dept. of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, Israel. Prof Zvi Livneh.
• Department of Molecular Biology, University of Geneva, Geneva, Switzerland. Director: Prof. T.D. Halazonetis
• Institute of Cancer Biology and Centre for Genotoxic Stress Research, Danish Cancer Society, Copenhagen, Denmark. Director: Prof. J. Bartek
• Telomeres and cellular senescence program, c/o IFOM-IEO, Milan, Italy. Head of Lab & Group: Dr F. d'Adda di Fagagna
• Department of Molecular Cell Biology, The Weizmann Institute of Science, Rehovot, Israel. Director: Prof. M. Oren
• Signalling and Cell Cycle Group, Spanish National Cancer Research Centre, Madrid, Spain. Head of Group: Prof. A. Nebreda
• The Norman and Helen Asher Chair of Cancer Research, Department of Molecular Cell Biology, The Weizmann Institute of Science Rehovot, Israel. Prof V. Rotter
• Department of Human Molecular Genetics and Biochemistry, Sackler Medical School, Tel Aviv University, Tel Aviv, Israel, Prof. Y. Shiloh
• Tumor Suppression Group, Molecular Oncology Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain. Prof. M Serrano
• School of Life Sciences, University of Dundee, UK. Prof. JJ Blow
• Lab of Human Carcinogenesis, NCI-CCR, National Institutes of Health, Bethesda, Maryland. Prof. C. Harris
• Genomic Instability Group, Roy Castle Institute for Lung Cancer Research. Liverpool, UK. Director: Prof. J.K. Field and Dr T. Liloglou
• Clinical Cytogenetics Laboratory, University of Columbia Medical Center, New York, USA. Director: Associate Professor B. Levy
• Ludwig Institute for Cancer Research, Box 595 Biomedical Center, Uppsala University, Uppsala, Sweden Head of Lab & Group: Dr A. Moustakas
• Understanding Cell Death in Tumour Cells Group, Beatson Institute for Cancer Research. Glasgow, Scotland. Head of Lab & Group: Dr. K. Ryan
• Kaplan Comprehensive Cancer Center, New York University School of Medicine and Veteran Affairs Medical Center New York, USA: P.I: Prof. X.R. Wu
• Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark. Prof. C.S. Sørensen
• Faculty Institute for Cancer Sciences, Manchester Academic Health Sciences Centre, University of Manchester, Manchester, UK. Prof PA Townsend
• Dept. Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden. Prof T. Frisan
• Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden. Prof T. Helleday
• Department of Molecular Medicine and Biotechnology, School of Medicine, University of Rijeka, Rijeka, Croatia. Prof. S. Volarevic
• IMBA, Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna Austria. Prof. J.M. Penninger
• Cancer Research UK, University of Manchester, Manchester, UK. Prof. C. Dive
• DNA repair, c/o IFOM-IEO, Milan, Italy. Dr D. Branzei
• Peter MacCallum Cancer Centre, Melbourne, Australia. Prof OA Martin
• Department of Genetics, The Life Sciences Institute, The Hebrew University , Jerusalem, Israel. Prof B Kerem
• School of Medicine-IMRIC-Immunology and Cancer Research, Hebrew University, Jerusalem, Israel. Prof R Aqeilan.
• Department of Microbiology and Molecular Genetics, Institute of Medical Research Israel-Canada, Hebrew University Medical School. Prof Itamar Simon.
• Intelligencia.ai, 180 Varick Street, 6th Floor, New York, NY 10014, US, www.intelligencia.ai